Synora Evidence home

About

Synora Evidence is a biostatistics consulting practice focused on hybrid control trials, real-world evidence, and causal inference.

Shu Yang

Founder
Professor of Statistics, North Carolina State University

Shu Yang graduated from Iowa State University in 2014, with a major in Mathematics and a co-major in Statistics. She was then a Postdoctoral Fellow in Biostatistics at the Harvard T.H. Chan School of Public Health before joining the faculty at North Carolina State University in 2016, where she is now Professor of Statistics.

Her research interests include causal inference from longitudinal observational data, real-world evidence studies, data integration and fusion methods, missing data analysis, semiparametric efficient estimation, survey sampling, and individualized treatment regimes. Much of her recent work develops methods for combining randomized trials with external and real-world data, including hybrid controlled trial designs.

  • Elected Fellow of the American Statistical Association (2026)
  • COPSS Emerging Leader Award (2024)
  • Co-Lead, ASA Biopharmaceutical Section Real-World Evidence Scientific Working Group
  • Associate Editor for journals including Statistics in Biopharmaceutical Research, Journal of the American Statistical Association, and Biometrics

Faculty website · Full publication list · LinkedIn

Selected publications

  • Gao, Y., Zhang, X., and Yang, S. (2026). Designing efficient hybrid and single-arm trials: external control borrowing and sample size calculation. Journal of the Royal Statistical Society: Series A.
  • Zhu, K., Yang, S., and Wang, X. (2025). Enhancing statistical validity and power in hybrid controlled trials: a randomization inference approach with conformal selective borrowing. ICML.
  • Gao, C., Yang, S., Shan, M., Ye, W., Lipkovich, I., and Faries, D. (2025). Improving randomized controlled trial analysis with data-adaptive borrowing. Biometrika.
  • Colnet, B., Mayer, I., Chen, G., et al., Josse, J., and Yang, S. (2024). Causal inference methods for combining randomized trials and observational studies: a review. Statistical Science.
  • Faries, D., Gao, C., Zhang, X., et al. (2024). Real effect or bias? Best practices for evaluating the robustness of real-world evidence through quantitative sensitivity analysis for unmeasured confounding. Pharmaceutical Statistics.
  • Yang, S., Gao, C., Wang, X., and Zeng, D. (2023). Elastic integrative analysis of randomized trial and real-world data for treatment heterogeneity estimation. Journal of the Royal Statistical Society: Series B.

See the full publication list.

Planning a trial that uses external or real-world data?

Get in touch early. Design choices made before a protocol is written, and before the first regulatory meeting, shape everything that follows.

Start a conversation